Meyer Thomas 13D and 13G filings for Altamira Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-27 4:30 pm Purchase |
2023-04-17 | 13D | Altamira Therapeutics Ltd. CYTO |
Meyer Thomas | 4,430 1.300% |
225 (+5.35%) |
Filing |
| 2023-01-18 4:30 pm Purchase |
2023-01-03 | 13D | Altamira Therapeutics Ltd. CYTO |
Meyer Thomas | 4,205 6.300% |
4,205 (New Position) |
Filing |